Mechanism of glycoprotein sorting and transport in the cells and its application for drug design
细胞内糖蛋白分选和运输机制及其在药物设计中的应用
基本信息
- 批准号:16390019
- 负责人:
- 金额:$ 9.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
FLAG-tagged ERGIC-53 was expressed with HA-tagged VIPL or VIP36 in 293T cells and pull down assay was performed from the cell lysates. HA-VIPL and HA-VIP36 were precipitated with ERGIC-53 indicating that these proteins interact with ERGIC-53. ERGIC-53 also interacted with MCFD2 in the presence of calcium, but neither VIP36 nor VIPL did. Surface plasmon resonance (SPR) experiment demonstrated that the interaction between ERGIC-53 and MCFD2 was susceptible to calcium ions, especially the concentration between 0.1 and 0.2 mM. MCFD2 mutants derived from F5F8D patients had three or four order of magnitude lower Ka values for ERGIC-53. Ultracentrifugation analysis and SPR experiment of soluble VIP36 indicating that sugar-binding activity of VIP36 was regulated by oligomer formation dependent on pH, which explains enhancement of avidity to sugar chains. Further FLET analysis using YGFP- and EGFP-fused VIP36 showed their interactions in the cells. In contrast, sugar-binding ability of ERGIC-53 … More was enhanced by MCFD2 interactions. The interaction of ERGIC-53 with MCFD2 depends on calcium concentration. By pull-down assay with VIP36, novel protein constitutively interacted with VIP36 was identified as a chaperone BiP. The interaction had different characteristics from those of chaperone substrates. Immunoelectron microscopic analysis showed that the binding of VIP36 to BiP was occurred especially in the endoplasmic reticulum (ER). Interestingly, VIP36 precipitated with BiP had sugar chains resistant to endo H suggesting that VIP36 transported retrogradely could bind to BiP in the ER. The binding of PE-labeled soluble ERGIC-53, VIP36, and VIPL tetramers to HeLaS3 cells showed their preferable binding to high mannose-type sugar chains. Inhibition analysis by a panel of high mannose-type sugar derivatives demonstrated the precise specificities of them. VIP36 and VIPL recognize Man α 2Man α 2Man arm and glucosylation of its non-reducing terminal abrogated their binding. ERGIC-53 preferencially bound to M8b isoform, which is a product of ER α-mannosidase I, indicating that newly synthesized glycoproteins may transferred from calnexin to ERGIC-53 via VIPL. VIP36 fused with CD8 transmembrane domain followed by intracellular domain of CD3ζ was expressed in HeLaS3 cells. The cell surface display system enabled us to pick up clones of mutated VIP36 having distinct sugar-binding specificities from random mutated VIP36 libraries. Less
FLAG标记的ERGIC-53与HA标记的VIPL或VIP 36在293 T细胞中表达,并从细胞裂解物进行下拉测定。HA-VIPL和HA-VIP 36与ERGIC-53发生沉淀,表明这些蛋白质与ERGIC-53相互作用。ERGIC-53在钙存在下也与MCFD 2相互作用,但VIP 36和VIPL都不与MCFD 2相互作用。表面等离子体共振(SPR)实验表明ERGIC-53与MCFD 2之间的相互作用对钙离子敏感,特别是在0.1 ~ 0.2 mM浓度范围内。F5 F8 D患者来源的MCFD 2突变体对ERGIC-53的Ka值降低了3 ~ 4个数量级。可溶性VIP 36的超离心分析和SPR实验表明,VIP 36的糖结合活性受依赖于pH的寡聚体形成的调节,这解释了对糖链的亲合力的增强。使用YGFP-和EGFP-融合的VIP 36的进一步FLET分析显示它们在细胞中的相互作用。相反,ERGIC-53的糖结合能力 ...更多信息 通过MCFD 2相互作用增强。ERGIC-53与MCFD 2的相互作用取决于钙浓度。通过与VIP 36的pull-down分析,鉴定了与VIP 36组成型相互作用的新蛋白为伴侣BiP。这种相互作用具有与分子伴侣底物不同的特点。免疫电镜分析表明,VIP 36与BiP的结合主要发生在内质网。有趣的是,用BiP沉淀的VIP 36具有对endo H有抗性的糖链,这表明逆行转运的VIP 36可以在ER中结合BiP。PE标记的可溶性ERGIC-53、VIP 36和VIPL四聚体与HeLaS 3细胞的结合显示它们优选与高甘露糖型糖链结合。通过一组高甘露糖型糖衍生物的抑制分析证明了它们的精确特异性。VIP 36和VIPL识别Man α 2 Man α 2 Man臂,其非还原末端的糖基化消除了它们的结合。ERGIC-53优先结合ER α-甘露糖苷酶I的产物M8 b亚型,表明新合成的糖蛋白可能通过VIPL从钙连接蛋白转移到ERGIC-53。在HeLaS 3细胞中表达了与CD 8跨膜结构域融合的VIP 36,随后是CD 3的胞内结构域。细胞表面展示系统使我们能够从随机突变的VIP 36文库中挑选具有不同糖结合特异性的突变的VIP 36的克隆。少
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM
- DOI:10.1016/j.imlet.2004.11.019
- 发表时间:2005-05-15
- 期刊:
- 影响因子:4.4
- 作者:Koganei, S;Ito, M;Matsumoto, N
- 通讯作者:Matsumoto, N
レクチン-歴史、構造・機能から応用まで-
凝集素 - 从历史、结构和功能到应用 -
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:K.Tajima;N.Matsumoto;K.Ohmori;H.Wada;K.Suzuki;K.Yamamoto;Y.Araki;山本一夫
- 通讯作者:山本一夫
MHC class I-like MILL molecules are beta2-microglobulin-associated, GPI-anchored glycoproteins that do not require TAP for cell surface expression.
MHC I 类 MILL 分子是 β2 微球蛋白相关、GPI 锚定的糖蛋白,不需要 TAP 进行细胞表面表达。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Kajikawa M;Baba T;Tomaru U;Watanabe Y;Koganei S;Tsuji-Kawahara S et al.
- 通讯作者:Tsuji-Kawahara S et al.
Ribosomal protein S18 identified as a cofilin-binding protein by using phage display library.
通过噬菌体展示文库鉴定核糖体蛋白 S18 为肌丝蛋白丝切蛋白结合蛋白。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kusui K.;Sasaki H.;Adachi R.;Matsui S.;Yamamoto K.;Yamaguchi T.;Kasahara T.;Suzuki K.
- 通讯作者:Suzuki K.
Detection of weak sugar binding activity of VIP36 using VIP36-streptavidin complex and membrane-based sugar chains
- DOI:10.1093/jh/mvm024
- 发表时间:2007-02-01
- 期刊:
- 影响因子:2.7
- 作者:Kawasaki, Norihito;Matsuo, Ichiro;Yamamoto, Kazuo
- 通讯作者:Yamamoto, Kazuo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAMAMOTO Kazuo其他文献
YAMAMOTO Kazuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAMAMOTO Kazuo', 18)}}的其他基金
Exploring a molecular mechanism governing the metabolism to repress cancer progression depending on genetic backgrounds
探索根据遗传背景控制新陈代谢以抑制癌症进展的分子机制
- 批准号:
18K07235 - 财政年份:2018
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of Fmr1-associated premature ovarian failure based on novel protein-protein interactions
基于新型蛋白质-蛋白质相互作用阐明 Fmr1 相关卵巢早衰的分子机制
- 批准号:
16K15709 - 财政年份:2016
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Dissecting the roles of metabolism in the development of cancer by means of the mitochondrial hyperactive model mice
通过线粒体过度活跃模型小鼠剖析新陈代谢在癌症发展中的作用
- 批准号:
26640082 - 财政年份:2014
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Lightning to a wind turbine in a wind farm and its influence on damages
风电场风机雷击及其损坏影响
- 批准号:
26420256 - 财政年份:2014
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of nuclear protein functions by N-acetylglucosamine modification
N-乙酰氨基葡萄糖修饰调节核蛋白功能
- 批准号:
24390015 - 财政年份:2012
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A novel method to identify nuclear proteins modified with N-acetylglucosamine by using a soluble glycosyltransferase having nuclear-localization signal
利用具有核定位信号的可溶性糖基转移酶鉴定 N-乙酰氨基葡萄糖修饰的核蛋白的新方法
- 批准号:
24659026 - 财政年份:2012
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Lightning Protections for Power, communication and control equipment in and in the vicinity of a wind turbine
风力涡轮机及其附近的电力、通信和控制设备的防雷保护
- 批准号:
23760274 - 财政年份:2011
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Study of super ferromagnetism formed in a self-assembled film of magnetic nanoparticles
磁性纳米颗粒自组装膜中形成的超铁磁性研究
- 批准号:
23710140 - 财政年份:2011
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Bioimaging of tumor markers using both engineered lectins and antibodies
使用工程凝集素和抗体对肿瘤标志物进行生物成像
- 批准号:
21390173 - 财政年份:2009
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The collapse of the mechanisms which stably maintain M phase chromosome and its biological effect
M期染色体稳定维持机制的崩溃及其生物学效应
- 批准号:
19310034 - 财政年份:2007
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
CAN/lectin 7信号通路调控棉铃虫对Cry1Ac蛋白的免疫机制解析
- 批准号:32172401
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
血栓调节蛋白lectin区优势突变引起血栓形成的分子机制及其干预措施
- 批准号:81973995
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
靶向Lectin受体多功能分子探针的构建及其在结直肠癌诊治中的实验研究
- 批准号:81371614
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
免疫识别因子lectin在鳞翅目寄主昆虫识别寄生蜂为“非我”过程中的作用机制研究
- 批准号:31272091
- 批准年份:2012
- 资助金额:85.0 万元
- 项目类别:面上项目
C型凝集素样受体识别在原发性皮肤毛霉病中的作用
- 批准号:81171510
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
水稻花粉优势表达的L-lectin受体激酶基因OsL-LecRK7的功能研究
- 批准号:31000605
- 批准年份:2010
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
腰带长体茧蜂胚胎表面Helix pomatia lectin结合蛋白保护其逃避寄主血细胞包囊反应的机制研究
- 批准号:30971964
- 批准年份:2009
- 资助金额:36.0 万元
- 项目类别:面上项目
相似海外基金
Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema
衰变加速因子 (CD55) 可防止香烟烟雾引起的肺气肿中凝集素途径介导的 AT2 细胞功能障碍
- 批准号:
10990669 - 财政年份:2024
- 资助金额:
$ 9.47万 - 项目类别:
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 9.47万 - 项目类别:
Elucidating mechanisms underlying multivalency modulating lectin-glycan binding and assembly properties-implications for lectin function regulation
阐明多价调节凝集素-聚糖结合和组装特性的机制-对凝集素功能调节的影响
- 批准号:
BB/Y005856/1 - 财政年份:2024
- 资助金额:
$ 9.47万 - 项目类别:
Research Grant
Role of CD44 bearing TJA-II binding glycans in therapy-resistant subset of triple negative breast cancer
携带 CD44 的 TJA-II 结合聚糖在三阴性乳腺癌耐药亚型中的作用
- 批准号:
23K06748 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Harnessing PET to Study the In Vivo Fate and Health Effects of Micro- and Nanoplastics
利用 PET 研究微塑料和纳米塑料的体内命运和健康影响
- 批准号:
10890903 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema
衰变加速因子 (CD55) 可防止香烟烟雾引起的肺气肿中凝集素途径介导的 AT2 细胞功能障碍
- 批准号:
10737359 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)
睡眠呼吸暂停加慢性阻塞性肺病(重叠综合征)对心血管的影响
- 批准号:
10733384 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Cell-free hemoglobin-oxidized LDL-LOX-1 axis and microvascular hyperpermeability during sepsis
脓毒症期间无细胞血红蛋白氧化的 LDL-LOX-1 轴和微血管通透性过高
- 批准号:
10739620 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
ELUCIDATING THE ROLE OF COATOMER COMPLEX COPI IN SKELETAL DYSPLASIA
阐明 COATOMER 复合物 COPI 在骨骼发育不良中的作用
- 批准号:
10591042 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:














{{item.name}}会员




